Shuttle Pharmaceuticals Holdings (SHPH) Times Interest Earned (2021 - 2026)
Shuttle Pharmaceuticals Holdings (SHPH) recorded quarterly Times Interest Earned of -$182.88 in Q1 2026, down 330.33% quarter-over-quarter from $79.4 in Q4 2025, and up 66.57% on a YoY basis from -$109.79 in Q1 2025.
Shuttle Pharmaceuticals Holdings (SHPH) Times Interest Earned (2021 - 2026) Analysis & Trends
Shuttle Pharmaceuticals Holdings' Times Interest Earned history runs 6 years deep, the most recent figure standing at -$182.88 for Q1 2026.
- In Q1 2026, Times Interest Earned rose 66.57% year-over-year to -$182.88; the TTM figure through Mar 2026 stood at $568.79 (up 4516.78% YoY), while the FY2025 annual figure was -$1365.0, down 54.17% from the prior year.
- Times Interest Earned was -$182.88 for Q1 2026 at Shuttle Pharmaceuticals Holdings, down from $79.4 in the prior quarter.
- In the past five years, Times Interest Earned ranged from a high of $190.7 in Q4 2022 to a low of -$3144.2 in Q3 2025.
- Historically, Times Interest Earned has averaged -$388.74 across 5 years, with a median of -$2.78 in 2024.
- The sharpest annual moves came in 2024 and 2025: Times Interest Earned sank 55572.6% in 2024, then soared 5216.88% in 2025.
- A 5-year view of Times Interest Earned shows it stood at $190.7 in 2022, then tumbled by 101.26% to -$2.41 in 2023, then soared by 161.94% to $1.49 in 2024, then jumped by 5216.88% to $79.4 in 2025, then sank by 330.33% to -$182.88 in 2026.
- The last three Times Interest Earned figures came in at -$182.88 (Q1 2026), $79.4 (Q4 2025), and -$3144.2 (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Times Interest Earned (Qtr) |
|---|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 39.72 Bn | 35.98 Bn | 1.97 Bn | - |
| 2 | Zoetis | 34.61 Bn | 32.67 Bn | 1.62 Bn | 13.44 |
| 3 | United Therapeutics | 24.07 Bn | 21.91 Bn | 648.10 Mn | 108.60 |
| 4 | Aurora Cannabis | 16.98 Bn | 16.91 Bn | 33.43 Mn | - |
| 5 | Neurocrine Biosciences | 16.64 Bn | 15.32 Bn | 800.70 Mn | - |
| 6 | Elanco Animal Health | 12.19 Bn | 11.76 Bn | 785.00 Mn | 5.39 |
| 7 | Alkermes | 7.37 Bn | 6.86 Bn | -116.06 Mn | -2.31 |
| 8 | Hims & Hers Health | 6.62 Bn | 5.87 Bn | 396.79 Mn | - |
| 9 | Lantheus Holdings | 6.47 Bn | 5.97 Bn | 230.92 Mn | 16.72 |
| 10 | Shuttle Pharmaceuticals Holdings | 2.17 Mn | 1.11 Mn | - | -182.88 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -182.88 |
| Dec 31, 2025 | 79.40 |
| Sep 30, 2025 | -3,144.16 |
| Jun 30, 2025 | -1,495.95 |
| Mar 31, 2025 | -547.03 |
| Dec 31, 2024 | 1.49 |
| Sep 30, 2024 | -1,427.96 |
| Jun 30, 2024 | -3.44 |
| Mar 31, 2024 | -2.78 |
| Dec 31, 2023 | -2.41 |
| Sep 30, 2023 | -2.56 |
| Jun 30, 2023 | -2.01 |
| Mar 31, 2023 | -2.58 |
| Dec 31, 2022 | 190.70 |
| Sep 30, 2022 | -59.85 |
| Jun 30, 2022 | -2.08 |
| Mar 31, 2022 | -4.39 |
| Dec 31, 2021 | 12.92 |
| Sep 30, 2021 | -2,142.62 |